(-)-Licarin B

CAS No. 51020-87-2

(-)-Licarin B ( Licarin B )

Catalog No. M18686 CAS No. 51020-87-2

1.(-)-Licarin B has anti-mycobacterial activity.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 63 In Stock
10MG 99 In Stock
25MG 164 In Stock
50MG 244 In Stock
100MG 365 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (-)-Licarin B
  • Note
    Research use only, not for human use.
  • Brief Description
    1.(-)-Licarin B has anti-mycobacterial activity.
  • Description
    Licarin B is a neolignan isolated from seeds of Myristica fragrans.
  • Synonyms
    Licarin B
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    anti-mycobacterial
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    51020-87-2
  • Formula Weight
    324.37
  • Molecular Formula
    C20H20O4
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    CC=CC1=CC2=C(C(=C1)OC)OC(C2C)C3=CC4=C(C=C3)OCO4
  • Chemical Name
    5-((2R,3R)-7-methoxy-3-methyl-5-((E)-prop-1-en-1-yl)-2,3-dihydrobenzofuran-2-yl)benzo[d][1,3]dioxole

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Citreorosein

    Citreorosein is a cAMP phosphodiesterase inhibitor, it has anti-inflammatory effect, inhibits proinflammatory cytokines production through the inhibition of both MAPKs and AKT-mediated IκB kinase (IKK) phosphorylation and subsequent inhibition of transcription factor NF-κB activation.

  • MEISi-2

    MEISi-2 is a potent MEIS inhibitor (MEISi). MEISi-2 significantly inhibits MEIS-luciferase reporters in vitro.

  • Byakangelicin

    Byakangelicin is an antineoplastic agent.